Peripheral Artery

  • 3E050 - Open
    • 3E0500
      • 3E05002 - Introduction Peripheral Artery to High-dose Interleukin-2 with Antineoplastic, Open Approach
      • 3E05003 - Introduction Peripheral Artery to Low-dose Interleukin-2 with Antineoplastic, Open Approach
      • 3E05005 - Introduction Peripheral Artery to Other Antineoplastic with Antineoplastic, Open Approach
      • 3E0500M - Introduction Peripheral Artery to Monoclonal Antibody with Antineoplastic, Open Approach
      • 3E0500P - Introduction Peripheral Artery to Clofarabine with Antineoplastic, Open Approach
    • 3E0501
      • 3E05016 - Introduction Peripheral Artery to Recombinant Human-activated Protein C with Thrombolytic, Open Approach
      • 3E05017 - Introduction Peripheral Artery to Other Thrombolytic with Thrombolytic, Open Approach
    • 3E0502
      • 3E05028 - Introduction Peripheral Artery to Oxazolidinones with Anti-infective, Open Approach
      • 3E05029 - Introduction Peripheral Artery to Other Anti-infective with Anti-infective, Open Approach
    • 3E0503
      • 3E0503Z - Introduction Peripheral Artery to No Qualifier with Anti-inflammatory, Open Approach
    • 3E0504
      • 3E0504Z - Introduction Peripheral Artery to No Qualifier with Serum, Toxoid and Vaccine, Open Approach
    • 3E0506
      • 3E0506Z - Introduction Peripheral Artery to No Qualifier with Nutritional Substance, Open Approach
    • 3E0507
      • 3E0507Z - Introduction Peripheral Artery to No Qualifier with Electrolytic and Water Balance Substance, Open Approach
    • 3E050F
      • 3E050FZ - Introduction Peripheral Artery to No Qualifier with Intracirculatory Anesthetic, Open Approach
    • 3E050G
      • 3E050GC - Introduction Peripheral Artery to Other Substance with Other Therapeutic Substance, Open Approach
      • 3E050GN - Introduction Peripheral Artery to Blood Brain Barrier Disruption with Other Therapeutic Substance, Open Approach
    • 3E050H
      • 3E050HZ - Introduction Peripheral Artery to No Qualifier with Radioactive Substance, Open Approach
    • 3E050K
      • 3E050KZ - Introduction Peripheral Artery to No Qualifier with Other Diagnostic Substance, Open Approach
    • 3E050N
      • 3E050NZ - Introduction Peripheral Artery to No Qualifier with Analgesics, Hypnotics, Sedatives, Open Approach
    • 3E050P
      • 3E050PZ - Introduction Peripheral Artery to No Qualifier with Platelet Inhibitor, Open Approach
    • 3E050R
      • 3E050RZ - Introduction Peripheral Artery to No Qualifier with Antiarrhythmic, Open Approach
    • 3E050T
      • 3E050TZ - Introduction Peripheral Artery to No Qualifier with Destructive Agent, Open Approach
    • 3E050V
      • 3E050VG - Introduction Peripheral Artery to Insulin with Hormone, Open Approach
      • 3E050VH - Introduction Peripheral Artery to Human B-type Natriuretic Peptide with Hormone, Open Approach
      • 3E050VJ - Introduction Peripheral Artery to Other Hormone with Hormone, Open Approach
    • 3E050W
      • 3E050WK - Introduction Peripheral Artery to Immunostimulator with Immunotherapeutic, Open Approach
      • 3E050WL - Introduction Peripheral Artery to Immunosuppressive with Immunotherapeutic, Open Approach
    • 3E050X
      • 3E050XZ - Introduction Peripheral Artery to No Qualifier with Vasopressor, Open Approach
  • 3E053 - Percutaneous
    • 3E0530
      • 3E05302 - Introduction Peripheral Artery to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach
      • 3E05303 - Introduction Peripheral Artery to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach
      • 3E05305 - Introduction Peripheral Artery to Other Antineoplastic with Antineoplastic, Percutaneous Approach
      • 3E0530M - Introduction Peripheral Artery to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
      • 3E0530P - Introduction Peripheral Artery to Clofarabine with Antineoplastic, Percutaneous Approach
    • 3E0531
      • 3E05316 - Introduction Peripheral Artery to Recombinant Human-activated Protein C with Thrombolytic, Percutaneous Approach
      • 3E05317 - Introduction Peripheral Artery to Other Thrombolytic with Thrombolytic, Percutaneous Approach
    • 3E0532
      • 3E05328 - Introduction Peripheral Artery to Oxazolidinones with Anti-infective, Percutaneous Approach
      • 3E05329 - Introduction Peripheral Artery to Other Anti-infective with Anti-infective, Percutaneous Approach
    • 3E0533
      • 3E0533Z - Introduction Peripheral Artery to No Qualifier with Anti-inflammatory, Percutaneous Approach
    • 3E0534
      • 3E0534Z - Introduction Peripheral Artery to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach
    • 3E0536
      • 3E0536Z - Introduction Peripheral Artery to No Qualifier with Nutritional Substance, Percutaneous Approach
    • 3E0537
      • 3E0537Z - Introduction Peripheral Artery to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach
    • 3E053F
      • 3E053FZ - Introduction Peripheral Artery to No Qualifier with Intracirculatory Anesthetic, Percutaneous Approach
    • 3E053G
      • 3E053GC - Introduction Peripheral Artery to Other Substance with Other Therapeutic Substance, Percutaneous Approach
      • 3E053GN - Introduction Peripheral Artery to Blood Brain Barrier Disruption with Other Therapeutic Substance, Percutaneous Approach
    • 3E053H
      • 3E053HZ - Introduction Peripheral Artery to No Qualifier with Radioactive Substance, Percutaneous Approach
    • 3E053K
      • 3E053KZ - Introduction Peripheral Artery to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
    • 3E053N
      • 3E053NZ - Introduction Peripheral Artery to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
    • 3E053P
      • 3E053PZ - Introduction Peripheral Artery to No Qualifier with Platelet Inhibitor, Percutaneous Approach
    • 3E053R
      • 3E053RZ - Introduction Peripheral Artery to No Qualifier with Antiarrhythmic, Percutaneous Approach
    • 3E053T
      • 3E053TZ - Introduction Peripheral Artery to No Qualifier with Destructive Agent, Percutaneous Approach
    • 3E053V
      • 3E053VG - Introduction Peripheral Artery to Insulin with Hormone, Percutaneous Approach
      • 3E053VH - Introduction Peripheral Artery to Human B-type Natriuretic Peptide with Hormone, Percutaneous Approach
      • 3E053VJ - Introduction Peripheral Artery to Other Hormone with Hormone, Percutaneous Approach
    • 3E053W
      • 3E053WK - Introduction Peripheral Artery to Immunostimulator with Immunotherapeutic, Percutaneous Approach
      • 3E053WL - Introduction Peripheral Artery to Immunosuppressive with Immunotherapeutic, Percutaneous Approach
    • 3E053X
      • 3E053XZ - Introduction Peripheral Artery to No Qualifier with Vasopressor, Percutaneous Approach